Showing results (621-630 of 649) with videos related to

Sort By:
Pageof 65
Hemasphere|October 9, 2024
Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemiaJin-Feng Ma, Jia-Wei Yan, Mei-Jing Liu, et al.
Hemasphere|October 9, 2024
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide studyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Hemasphere|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemiaTim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos, et al.
Hemasphere|April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patientsLukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Hemasphere|April 25, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapyAndrea Manubens, Bruno Paiva, Norma C Gutiérrez, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Hemasphere|April 17, 2025
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP RegistryInés Gómez-Seguí, Joan Cid, Miquel Lozano, et al.
Hemasphere|April 9, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse riskKrystof Seferna, Michael Svaton, Andrea Rennerova, et al.
Hemasphere|April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.
Pageof 65